Oligonucleotide aptamers: new tools for targeted cancer therapy.
about
Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer TherapyBone site-specific delivery of siRNASynthetic biology for pharmaceutical drug discoveryProgress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery SystemsNucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical SensingDNA Aptamers in the Diagnosis and Treatment of Human DiseasesRecent Methods for Purification and Structure Determination of OligonucleotidesDevelopment of Cell-SELEX Technology and Its Application in Cancer Diagnosis and TherapyTherapeutic aptamers: developmental potential as anticancer drugsssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 CellsStructural computational modeling of RNA aptamersA Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal AdenocarcinomaEnrichment and single-cell analysis of circulating tumor cells.Analyzing HT-SELEX data with the Galaxy Project tools--A web based bioinformatics platform for biomedical research.Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of gliomaSelection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersMolecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.Selective Targeting to Glioma with Nucleic Acid AptamersLigand-targeted theranostic nanomedicines against cancerEfficient enzymatic synthesis and dual-colour fluorescent labelling of DNA probes using long chain azido-dUTP and BCN dyesLibrary-based display technologies: where do we stand?Contrast agents for molecular photoacoustic imaging.Ligand-guided selection of aptamers against T-cell Receptor-cluster of differentiation 3 (TCR-CD3) expressed on Jurkat.E6 cells.Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface AntigensDNA display of folded RNA libraries enabling RNA-SELEX without reverse transcription.Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects.Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells.Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.Evoking picomolar binding in RNA by a single phosphorodithioate linkage.DNA Walker-Regulated Cancer Cell Growth Inhibition.Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imagingOptical Aptamer Probes of Fluorescent Imaging to Rapid Monitoring of Circulating Tumor Cell.Long non-coding RNA EWSAT1 promotes human nasopharyngeal carcinoma cell growth in vitro by targeting miR-326/-330-5p.Efficient functional neutralization of lethal peptide toxins in vivo by oligonucleotidesThree-dimensional modeling of single stranded DNA hairpins for aptamer-based biosensorsAptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy.Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.New Modalities for Challenging Targets in Drug Discovery.A self-assembling RNA aptamer-based nanoparticle sensor for fluorometric detection of Neomycin B in milk.
P2860
Q26744832-243793C6-6CC8-44FA-851A-41DB3F3D0303Q26773973-BCF2D4C9-8FE0-4C55-A41D-135CB9FC112EQ26775582-198187AF-2084-4161-8EA6-54936B6DBBDAQ26782485-340307F9-3D73-4A1A-83C4-B68ACD7EBF37Q26825644-5508ACF3-FBCF-480D-87F8-5EE7ABD743A4Q26864314-B10233F0-A6EE-4ED4-8409-BEA33F575F95Q28076851-FA4B964D-43D2-4DF9-9EA1-1FCB8D6BF43EQ28080168-3467A2D4-AFD8-457D-81D3-5CFD0F31F8C6Q28085157-D58B6344-9B43-4F62-BEE2-2214F34CC23BQ28552859-BE2DC00E-0372-41C1-A19A-DB207B0E9D64Q28828891-C09981DA-8ECE-4CD6-B8A2-D28ABB86BB70Q30275702-D43AFB6C-F230-45D9-A469-86C34F6800ECQ30357985-EDF7EC38-08DC-4C3E-A54B-C1BCEDC7AC86Q31007883-48C81584-7AA9-435A-A5C0-5F857264BEDAQ33588273-AB2B3D8C-0CF6-4AFD-8EB4-E61A50A49CAEQ33734403-94F6D142-FFD4-4FF8-B1A0-A2C6F90A9B32Q33832781-30BDCCE1-54C0-4A0E-ADFA-B558B68D32B2Q35621766-D759A97E-503C-42C3-A4C0-0D40D8E3882CQ35740074-4F019200-D673-417A-8991-EA4E93F8B567Q35895637-ADF60C43-D250-4191-B06E-869984AB06F2Q35906675-B4A59FB0-2CBD-4B3C-9890-F5834EA14B0AQ36053596-BAD8CA27-910B-4EC1-840D-4C4618CB2F58Q36088783-47949A73-2058-4412-95B1-AE1FDF27982DQ36103201-13C94FD6-330B-490F-AA30-D3F8139885E7Q36266158-F9FBC581-CB50-4E6A-9EAC-00354299D152Q36285843-27192E19-1E36-4A00-AF4C-AA63C42FC044Q36644318-A361DD96-39D9-4ED5-B0C1-9B2978F65862Q36689755-6462DEFD-3F49-4E36-BEA5-EF5DE8F91ABFQ36782499-71603390-0330-470D-880C-E182D4A98494Q37294897-33B8FBA8-B6A2-4424-8681-143C6E602BDBQ37312243-75173A99-8ACF-4907-BA44-D5BD8E5A5B48Q37392736-F717FFEA-BF55-4220-8888-FD87985564D7Q37467334-CF8A283A-C5B7-4C65-83D6-D8BDB0C6B98DQ37530948-767E87AB-269B-4A63-B7EE-51C84B78DA63Q38287575-DEB9A929-5918-4DC4-ABF1-D7D0118D9010Q38288270-5B1190C6-C316-4A6B-AB4D-89C93A1D317FQ38288291-8950DD09-3D41-441E-9F69-6000F7EB8BCEQ38288965-E2C0F148-4683-4EBA-910A-B520F69BF29FQ38289100-4EA8119A-82CC-4DA0-A642-6C96F86151E5Q38293412-1E0423AE-4E1E-431E-9111-4AF137F5078D
P2860
Oligonucleotide aptamers: new tools for targeted cancer therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Oligonucleotide aptamers: new tools for targeted cancer therapy.
@en
type
label
Oligonucleotide aptamers: new tools for targeted cancer therapy.
@en
prefLabel
Oligonucleotide aptamers: new tools for targeted cancer therapy.
@en
P2093
P2860
P356
P1476
Oligonucleotide aptamers: new tools for targeted cancer therapy.
@en
P2093
Hongguang Sun
Patrick Y Lu
Roberto R Rosato
P2860
P356
10.1038/MTNA.2014.32
P50
P577
2014-08-05T00:00:00Z